Fair Value Measurements - Roll Forward (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Mar. 29, 2025 |
Mar. 30, 2024 |
Mar. 29, 2025 |
Mar. 30, 2024 |
|
Fair Value Disclosures [Abstract] | ||||
Beginning balance | $ 1.1 | $ 3.7 | $ 1.1 | $ 2.0 |
Contingent consideration recorded at acquisition | 0.0 | 0.0 | 0.0 | 0.0 |
Fair value adjustments | 0.0 | 0.0 | 0.0 | 1.7 |
Payments | 0.0 | (2.6) | 0.0 | (2.6) |
Ending balance | $ 1.1 | $ 1.1 | $ 1.1 | $ 1.1 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|